(HealthDay)—From 2016 to 2018, there were increases in the rates of vaginal birth after cesarean delivery (VBAC), reaching 13.3 percent in 2018, according to a March data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Read More

(HealthDay)—For patients with HIV-1 suppression, long-acting cabotegravir plus rilpivirine is noninferior to oral therapy with dolutegravir-abacavir-lamivudine and standard oral therapy, according to two studies published online March 4 in the New England Journal of Medicine.
Read More

In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.
Read More

For years, curry lovers have sworn by the anti-inflammatory properties of turmeric, but its active compound, curcumin, has long frustrated scientists hoping to validate these claims with clinical studies.
Read More

The three-decade study showed no association between moderate egg consumption and risk of heart disease

Read More

DEAR MAYO CLINIC: I was always led to believe that leaking urine while sneezing or exercising is part of life for women after menopause, but my health care provider tells me that isn’t necessarily true. I’ve tried Kegel exercises, but those don’t seem to help. Would pelvic floor therapy be a good next step? What does that involve?
Read More

Herbal supplements are natural, so they must be safe, right? Not necessarily.
Read More

In January 1934, officials at the Hill School learned a student had been exposed to measles over winter break and confined him to the infirmary.
Read More

Mice exposed to stress in the womb and soon after birth can expect a lifetime of immune system deficiencies that hinder the ability to ward off infections and cancer, Yale University researchers report March 5 in the journal Cell.
Read More

Cleveland Clinic researchers have identified a gut microbe generated byproduct—phenylacetylglutamine (PAG) – that is linked to development of cardiovascular disease, including heart attack, stroke and death. The study was published in Cell today.
Read More